YEEHAW CANDIDATES Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Galirayo who wrote (6507)	1/17/2005 11:17:29 AM
From: Gulo	Read Replies (1) of 23958

TA is still a bit mysterious to me. 10 black candles, 2 white candles - do we dance around the altar now? Are you sure you see two white candles? It's a bit smoky in this cave. <g> The FA on NEOL is not terribly compelling. Of course, one can't do normal valuation on NEOL because it has no sales. They have $4/share in cash and a couple of drug candidates. Their main candidate IL13-PE38QQR has some promise, but it has had promise for a few years already. It has orphan drug status in Europe and the U.S. and the Japanese rights were recently sold for a measly $2M with up to $12M in future payments. That doesn't give me much confidence that the company is worth much more than its cash. In fact, given the cash burn, I would value NEOL at less than $4. That doesn't mean that the stock price will go down to $4 anytime soon - especially if your candle-lit divination ritual suggests otherwise. I'm quite happy that I sold when I did, and I'm glad I didn't get back in (thanks in part to your comments after the white initial candle). My gut read of the chart is that you are right to suspect that NEOL might take off to the upside soon, but I'll pass. -g

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next